Last reviewed · How we verify
BioBlock® antiviral nasal spray — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
BioBlock® antiviral nasal spray (BioBlock® antiviral nasal spray) — Chemi-Pharm AS.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BioBlock® antiviral nasal spray TARGET | BioBlock® antiviral nasal spray | Chemi-Pharm AS | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BioBlock® antiviral nasal spray CI watch — RSS
- BioBlock® antiviral nasal spray CI watch — Atom
- BioBlock® antiviral nasal spray CI watch — JSON
- BioBlock® antiviral nasal spray alone — RSS
Cite this brief
Drug Landscape (2026). BioBlock® antiviral nasal spray — Competitive Intelligence Brief. https://druglandscape.com/ci/bioblock-antiviral-nasal-spray. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab